Showing 41 - 50 of 58
Younger patients with fewer comorbidities were more likely to receive chemotherapy and had longer survival. AML is associated with a substantial economic burden, and treatment outcomes appear to be suboptimal, with limited therapy options currently available. </AbstractSection> Copyright Springer International...
Persistent link: https://www.econbiz.de/10011000714
Healthcare costs were twice as high among influenza patients with complications versus those without, with inpatient and outpatient services being the primary cost drivers. Now with the universal recommendation for seasonal influenza vaccination for all individuals ≥6 months of age,...
Persistent link: https://www.econbiz.de/10011000810
The per-patient cost of advanced melanoma is high. Hospital services are the largest component of these costs. Monthly costs for subjects with stage IV melanoma were 67% higher than costs for subjects with stage IIIC disease and 3-fold higher than costs for patients with stages IIIA/B and IIB/C....
Persistent link: https://www.econbiz.de/10011000825
While the advent of vaccines for Haemophilus influenzae and Streptococcus pneumoniae has curtailed invasive bacterial infection rates, IMD continues to be a public health concern that presents greatly increased hospital costs, LOS and mortality risk, particularly for infants and adolescents. </AbstractSection>...
Persistent link: https://www.econbiz.de/10011000841
Persistent link: https://www.econbiz.de/10004075072
Persistent link: https://www.econbiz.de/10004016334
Persistent link: https://www.econbiz.de/10004016335
Persistent link: https://www.econbiz.de/10005326769
Persistent link: https://www.econbiz.de/10005354180
Persistent link: https://www.econbiz.de/10004304134